600422 昆药集团
已收盘 05-07 15:00:00
资讯
新帖
简况
每周股票复盘：昆药集团（600422）因股价跌幅偏离上榜龙虎榜
证券之星 · 05-02
每周股票复盘：昆药集团（600422）因股价跌幅偏离上榜龙虎榜
港股异动 | 华润医药(03320)早盘跌超5% 旗下多家公司发布一季度业绩 昆药集团首次一季度亏损
智通财经网 · 04-27
港股异动 | 华润医药(03320)早盘跌超5% 旗下多家公司发布一季度业绩 昆药集团首次一季度亏损
异动快报：昆药集团（600422）4月27日9点34分触及跌停板
证券之星 · 04-27
异动快报：昆药集团（600422）4月27日9点34分触及跌停板
营收退回十年前、单季亏1.42亿，昆药集团转型阵痛待破局
21世纪经济报道 · 04-27
营收退回十年前、单季亏1.42亿，昆药集团转型阵痛待破局
昆药集团(600422)3月31日股东户数5.56万户，较上期增加0.29%
证券之星 · 04-25
昆药集团(600422)3月31日股东户数5.56万户，较上期增加0.29%
图解昆药集团一季报：第一季度单季净利润同比下降256.70%
证券之星 · 04-25
图解昆药集团一季报：第一季度单季净利润同比下降256.70%
华润医药(03320)：昆药集团一季度净亏损1.45亿元 同比盈转亏
智通财经 · 04-24
华润医药(03320)：昆药集团一季度净亏损1.45亿元 同比盈转亏
每周股票复盘：昆药集团（600422）2026年第一次临时股东会顺利召开
证券之星 · 04-19
每周股票复盘：昆药集团（600422）2026年第一次临时股东会顺利召开
昆药集团（600422）披露2026年第一次临时股东会决议公告，4月17日股价下跌0.98%
证券之星 · 04-17
昆药集团（600422）披露2026年第一次临时股东会决议公告，4月17日股价下跌0.98%
每周股票复盘：昆药集团（600422）高管变更，张梦珣辞任多职
证券之星 · 04-05
每周股票复盘：昆药集团（600422）高管变更，张梦珣辞任多职
昆药集团（600422）披露高级管理人员变更公告，4月3日股价下跌2.55%
证券之星 · 04-03
昆药集团（600422）披露高级管理人员变更公告，4月3日股价下跌2.55%
每周股票复盘：昆药集团（600422）拟定增补三名董事
证券之星 · 03-29
每周股票复盘：昆药集团（600422）拟定增补三名董事
昆药集团（600422）披露召开2026年第一次临时股东会的通知，3月23日股价下跌4.18%
证券之星 · 03-23
昆药集团（600422）披露召开2026年第一次临时股东会的通知，3月23日股价下跌4.18%
开源证券：给予昆药集团买入评级
证券之星 · 03-23
开源证券：给予昆药集团买入评级
昆药集团（600422）2025年年报简析：净利润同比下降46%
证券之星 · 03-21
昆药集团（600422）2025年年报简析：净利润同比下降46%
昆药集团(600422.SH)发布2025年度业绩，归母净利润3.5亿元，同比下降46.00%
智通财经 · 03-19
昆药集团(600422.SH)发布2025年度业绩，归母净利润3.5亿元，同比下降46.00%
华润医药旗下昆药集团拟每10股派发现金红利1.80元
美股速递 · 03-19
华润医药旗下昆药集团拟每10股派发现金红利1.80元
华润医药旗下昆药集团全年初步归属股东净利润达3.499亿元
美股速递 · 02-06
华润医药旗下昆药集团全年初步归属股东净利润达3.499亿元
昆药集团(600422.SH)2025年度归母净利润预计3.5亿元 同比下降46%
智通财经网 · 02-06
昆药集团(600422.SH)2025年度归母净利润预计3.5亿元 同比下降46%
昆药集团：股价波动受多重因素影响
证券日报 · 02-04
昆药集团：股价波动受多重因素影响
加载更多
公司概况
公司名称：
昆药集团股份有限公司
所属行业：
医药制造业
上市日期：
2000-12-06
主营业务：
昆药集团股份有限公司的主营业务是药物研发、生产及销售、医药流通及大健康产业。公司的主要产品是心脑血管治疗领域、骨科系列、抗疟类、妇科、消化系统、其他、药品、器械批发与零售。公司是国家认定企业技术中心、国家高新技术创新示范企业、国家知识产权示范企业，全国医药制造业百强企业。
发行价格：
10.22
{"stockData":{"symbol":"600422","market":"SH","secType":"STK","nameCN":"昆药集团","latestPrice":9.33,"timestamp":1778137201000,"preClose":9.52,"halted":0,"volume":9908460,"delay":0,"changeRate":-0.02,"floatShares":757000000,"shares":757000000,"eps":0.1555,"marketStatus":"已收盘","change":-0.19,"latestTime":"05-07 15:00:00","open":9.5,"high":9.56,"low":9.31,"amount":93273900,"amplitude":0.0263,"askPrice":9.34,"askSize":961,"bidPrice":9.33,"bidSize":943,"shortable":0,"etf":0,"ttmEps":0.1555,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778203800000},"marketStatusCode":5,"adr":0,"adjPreClose":9.52,"symbolType":"stock","openAndCloseTimeList":[[1778117400000,1778124600000],[1778130000000,1778137200000]],"highLimit":10.47,"lowLimit":8.57,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":756975757,"isCdr":false,"pbRate":1.35,"roa":"--","peRate":60,"roe":"--","epsLYR":0.46,"committee":0.415245,"marketValue":7063000000,"turnoverRate":0.0131,"status":1,"floatMarketCap":7063000000},"requestUrl":"/m/hq/s/600422","defaultTab":"news","newsList":[{"id":"2632623768","title":"每周股票复盘：昆药集团（600422）因股价跌幅偏离上榜龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2632623768","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632623768?lang=zh_cn&edition=full","pubTime":"2026-05-02 06:33","pubTimestamp":1777674789,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，昆药集团报收于9.5元，较上周的10.96元下跌13.32%。本周，昆药集团4月27日盘中最高价报9.95元。本周关注点交易信息汇总：昆药集团因日收盘价格跌幅偏离值达7%登上龙虎榜交易信息汇总：此次为近5个交易日内第1次上榜交易信息汇总沪深交易所2026年4月27日公布的交易公开信息显示，昆药集团因有价格涨跌幅限制的日收盘价格跌幅偏离值达到7%的前五只证券登上龙虎榜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200003584.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","600422","BK0239","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630356686","title":"港股异动 | 华润医药(03320)早盘跌超5% 旗下多家公司发布一季度业绩 昆药集团首次一季度亏损","url":"https://stock-news.laohu8.com/highlight/detail?id=2630356686","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630356686?lang=zh_cn&edition=full","pubTime":"2026-04-27 11:18","pubTimestamp":1777259883,"startTime":"0","endTime":"0","summary":"华润医药(03320)早盘跌超5%，截至发稿，跌5.54%，报54.6港元，成交额8960.6万港元。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20260427/20260427111827_60015.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260427/20260427111827_60015.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434225.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0028","BK1191","BK4588","03320","VXUS","BK0239","BK1570","600422","BK4585","BK0060","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630643358","title":"异动快报：昆药集团（600422）4月27日9点34分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2630643358","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630643358?lang=zh_cn&edition=full","pubTime":"2026-04-27 09:36","pubTimestamp":1777253788,"startTime":"0","endTime":"0","summary":"证券之星4月27日盘中消息，9点34分昆药集团（600422）触及跌停板。其所属行业中药目前上涨。领涨股为济川药业。该股为大农业，农业种植，口腔概念热股。4月24日的资金流向数据方面，主力资金净流出1000.61万元，占总成交额13.47%，游资资金净流出311.34万元，占总成交额4.19%，散户资金净流入1311.94万元，占总成交额17.66%。近5日资金流向一览见下表：昆药集团主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700010094.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600422","BK0188","BK0239","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630358404","title":"营收退回十年前、单季亏1.42亿，昆药集团转型阵痛待破局","url":"https://stock-news.laohu8.com/highlight/detail?id=2630358404","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630358404?lang=zh_cn&edition=full","pubTime":"2026-04-27 08:30","pubTimestamp":1777249800,"startTime":"0","endTime":"0","summary":" 4月24日晚，昆药集团发布2026年第一季度财报，交出了一份近十年来最为低迷的季度成绩单。 财报显示，今年一季度公司实现营收8.36亿元，同比大幅下滑48.01%，回落至十年前水平；归母净利润亏损1.42亿元，出现20年来一季度首次亏损；经营活动现金流净额跌至-6.14亿元，创下20年来一季度新低。 梳理财报可见，昆药集团收入和利润端的下滑并非突发。 2023年至2025年，公司营收分别同比下降6.99%、0.34%、21.74%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-04-27/doc-inhvwwms7939250.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-04-27/doc-inhvwwms7939250.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["600422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630870898","title":"昆药集团(600422)3月31日股东户数5.56万户，较上期增加0.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630870898","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630870898?lang=zh_cn&edition=full","pubTime":"2026-04-25 17:03","pubTimestamp":1777107804,"startTime":"0","endTime":"0","summary":"证券之星消息，近日昆药集团披露，截至2026年3月31日公司股东户数为5.56万户，较2月28日增加158.0户，增幅为0.29%。在中药行业个股中，昆药集团股东户数高于行业平均水平，截至3月31日，中药行业平均股东户数为5.31万户。从股价来看，2026年2月28日至2026年3月31日，昆药集团区间跌幅为7.17%，在此期间股东户数增加158.0户，增幅为0.29%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042500031904.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0060","BK0028","BK0239","600422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630582121","title":"图解昆药集团一季报：第一季度单季净利润同比下降256.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630582121","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630582121?lang=zh_cn&edition=full","pubTime":"2026-04-25 02:18","pubTimestamp":1777054735,"startTime":"0","endTime":"0","summary":"证券之星消息，昆药集团2026年一季报显示，一季度公司主营收入8.36亿元，同比下降48.01%；归母净利润-1.42亿元，同比下降256.7%；扣非净利润-1.9亿元，同比下降363.98%；负债率39.39%，投资收益1962.75万元，财务费用1062.15万元，毛利率22.57%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042500006474.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629845690","title":"华润医药(03320)：昆药集团一季度净亏损1.45亿元 同比盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2629845690","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629845690?lang=zh_cn&edition=full","pubTime":"2026-04-24 19:29","pubTimestamp":1777030156,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华润医药(03320)发布昆药集团截止2026年3月31日止3个月财务业绩，该公司取得营业总收入8.36亿元，同比减少48.01%;净亏损1.45亿元，去年同期溢利1.14亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433598.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600422","BK0060","BK0239","03320","BK1570","BK0188","BK1191","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628596007","title":"每周股票复盘：昆药集团（600422）2026年第一次临时股东会顺利召开","url":"https://stock-news.laohu8.com/highlight/detail?id=2628596007","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628596007?lang=zh_cn&edition=full","pubTime":"2026-04-19 02:40","pubTimestamp":1776537617,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，昆药集团报收于11.17元，较上周的11.31元下跌1.24%。本周，昆药集团4月15日盘中最高价报11.4元。本周关注点公司公告汇总：昆药集团2026年第一次临时股东会审议通过增补董事、担保计划及融资额度三项议案。公司公告汇总北京德恒（昆明）律师事务所就昆药集团股份有限公司2026年第一次临时股东会的召集、召开程序、出席会议人员资格、表决程序和表决结果出具法律意见。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900000887.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","600422","BK0028","BK0060","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628202069","title":"昆药集团（600422）披露2026年第一次临时股东会决议公告，4月17日股价下跌0.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628202069","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628202069?lang=zh_cn&edition=full","pubTime":"2026-04-17 22:16","pubTimestamp":1776435376,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，昆药集团报收于11.17元，较前一交易日下跌0.98%，最新总市值为84.55亿元。近日，昆药集团披露《北京德恒（昆明）律师事务所关于昆药集团股份有限公司2026年第一次临时股东会的法律意见》。公告显示，公司2026年第一次临时股东会于2026年4月17日召开，审议通过了增补第十一届董事会部分非独立董事、2026年度担保计划及融资额度三项议案。北京德恒（昆明）律师事务所认为本次股东会的召集、召开、表决程序和结果合法有效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041700045816.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600422","BK0028","BK0239","BK0060","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625946619","title":"每周股票复盘：昆药集团（600422）高管变更，张梦珣辞任多职","url":"https://stock-news.laohu8.com/highlight/detail?id=2625946619","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625946619?lang=zh_cn&edition=full","pubTime":"2026-04-05 03:11","pubTimestamp":1775329869,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，昆药集团报收于11.46元，较上周的11.4元上涨0.53%。本周，昆药集团4月2日盘中最高价报11.8元。昆药集团当前最新总市值86.75亿元，在中药板块市值排名24/67，在两市A股市值排名2138/5193。公司于2026年3月31日召开十一届十七次董事会会议，审议通过聘任孙志强先生为公司董事会秘书，任期自董事会审议通过之日起至十一届董事会届满之日止。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040500000879.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","600422","BK0028","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624440651","title":"昆药集团（600422）披露高级管理人员变更公告，4月3日股价下跌2.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624440651","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624440651?lang=zh_cn&edition=full","pubTime":"2026-04-03 18:19","pubTimestamp":1775211554,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，昆药集团报收于11.46元，较前一交易日下跌2.55%，最新总市值为86.75亿元。该股当日开盘11.68元，最高11.69元，最低11.38元，成交额达9265.96万元，换手率为1.06%。昆药集团于近日披露《关于高级管理人员变更的公告》。公司于2026年3月31日召开十一届十七次董事会会议，审议通过聘任孙志强先生为公司董事会秘书，任期自董事会审议通过之日起至十一届董事会届满之日止。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300035551.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0060","BK0028","600422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623380795","title":"每周股票复盘：昆药集团（600422）拟定增补三名董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2623380795","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623380795?lang=zh_cn&edition=full","pubTime":"2026-03-29 02:52","pubTimestamp":1774723930,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，昆药集团报收于11.4元，较上周的11.71元下跌2.65%。本周，昆药集团3月23日盘中最高价报11.6元。本周关注点公司公告汇总：昆药集团拟定增补王亮、钟江、邓康为非独立董事。12名董事全部参与表决并全票通过各项议案。会议将审议增补王亮、钟江、邓康为十一届董事会非独立董事，中小投资者对此议案将单独计票。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032900000562.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0060","600422","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621704682","title":"昆药集团（600422）披露召开2026年第一次临时股东会的通知，3月23日股价下跌4.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621704682","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621704682?lang=zh_cn&edition=full","pubTime":"2026-03-23 22:16","pubTimestamp":1774275382,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，昆药集团报收于11.22元，较前一交易日下跌4.18%，最新总市值为84.93亿元。该股当日开盘11.55元，最高11.6元，最低11.08元，成交额达1.38亿元，换手率为1.61%。近日，昆药集团股份有限公司发布《关于召开2026年第一次临时股东会的通知》。公告显示，公司将于2026年4月17日召开2026年第一次临时股东会，会议采取现场投票与网络投票相结合的方式，网络投票通过上海证券交易所系统进行。股权登记日为2026年4月10日，登记时间为2026年4月13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300039723.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0060","BK0239","600422","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621772508","title":"开源证券：给予昆药集团买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2621772508","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621772508?lang=zh_cn&edition=full","pubTime":"2026-03-23 18:16","pubTimestamp":1774260993,"startTime":"0","endTime":"0","summary":"开源证券股份有限公司余汝意,巢舒然近期对昆药集团进行研究并发布了研究报告《公司信息更新报告：2025年经营承压，砺行克难扎实推进业务发展》，给予昆药集团买入评级。 昆药集团 经营业绩承压，看好银发健康布局成长潜力，维持“买入”评级 公司2025年实现营收65.75亿元；归母净利润3.50亿元；扣非归母净利润1.07亿元。最新盈利预测明细如下：该股最近90天内共有4家机构给出评级，买入评级3家，增持评级1家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300031246.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600422","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621578187","title":"昆药集团（600422）2025年年报简析：净利润同比下降46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621578187","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621578187?lang=zh_cn&edition=full","pubTime":"2026-03-21 06:03","pubTimestamp":1774044204,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期昆药集团发布2025年年报。根据财报显示，昆药集团净利润同比下降46%。截至本报告期末，公司营业总收入65.75亿元，同比下降21.74%，归母净利润3.5亿元，同比下降46.0%。按单季度数据看，第四季度营业总收入18.24亿元，同比下降29.88%，第四季度归母净利润8057.3万元，同比下降60.4%。持有昆药集团最多的基金为景顺长城资源垄断混合A，目前规模为16.99亿元，最新净值0.55，较上一交易日下跌0.72%，近一年上涨18.63%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032100004468.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620240058","title":"昆药集团(600422.SH)发布2025年度业绩，归母净利润3.5亿元，同比下降46.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620240058","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620240058?lang=zh_cn&edition=full","pubTime":"2026-03-19 20:25","pubTimestamp":1773923136,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昆药集团(600422.SH)发布2025年年度报告，报告期内，公司实现营业收入65.75亿元，同比下降21.74%。实现归属于上市公司股东的净利润3.5亿元，同比下降46.00%。实现归属于上市公司股东的扣除非经常性损益的净利润1.07亿元，同比下降74.45%。基本每股收益为0.46元。拟向全体股东每10股派发现金红利1.8元(含税)。营业收入变动原因说明：主要系外部环境中成药集采进度不及预期、医保控费深化,院内存量业务承压，增量业务尚处成长期;零售终端受客流波动、竞争加剧及动销放缓影响，精品国药板块部分产品仍在渠道拓展阶段,共同导致2025年销售规模有所回落。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416132.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"昆药集团(600422.SH)发布2025年度业绩，归母净利润3.5亿元，同比下降46.00%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125615969","title":"华润医药旗下昆药集团拟每10股派发现金红利1.80元","url":"https://stock-news.laohu8.com/highlight/detail?id=1125615969","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125615969?lang=zh_cn&edition=full","pubTime":"2026-03-19 20:14","pubTimestamp":1773922493,"startTime":"0","endTime":"0","summary":"华润医药集团旗下的昆药集团宣布，公司计划向股东实施现金分红方案，拟每10股派发1.80元人民币的现金股利。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","03320","BK1570","BK1191","BK0028","600422","BK0188","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155665228","title":"华润医药旗下昆药集团全年初步归属股东净利润达3.499亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1155665228","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155665228?lang=zh_cn&edition=full","pubTime":"2026-02-06 20:05","pubTimestamp":1770379542,"startTime":"0","endTime":"0","summary":"华润医药集团有限公司（股票代码：03320）近日披露，其控股子公司昆药集团股份有限公司（股票代码：600422）公布的全年初步财务数据显示，报告期内归属于上市公司股东的净利润为3.499亿元人民币。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","600422","BK1570","BK0239","BK0060","03320","BK0188","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609934566","title":"昆药集团(600422.SH)2025年度归母净利润预计3.5亿元 同比下降46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609934566","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609934566?lang=zh_cn&edition=full","pubTime":"2026-02-06 17:18","pubTimestamp":1770369517,"startTime":"0","endTime":"0","summary":"昆药集团(600422.SH)披露2025年度业绩快报，公司累计实现营业收入预计65.77亿元，较上年同期下降21.72%;实现归母净利润预计3.5亿元，同比下降46%。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/astock/3.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/3.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402580.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"昆药集团(600422.SH)2025年度归母净利润预计3.5亿元 同比下降46%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["600422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608676613","title":"昆药集团：股价波动受多重因素影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2608676613","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608676613?lang=zh_cn&edition=full","pubTime":"2026-02-04 21:37","pubTimestamp":1770212220,"startTime":"0","endTime":"0","summary":"证券日报网讯 2月4日，昆药集团在互动平台回答投资者提问时表示，上市公司股价在二级市场的走势及波动也受到包括行业政策在内的多重因素影响，敬请投资者注意投资风险。公司管理层始终高度专注自身的经营管理，致力提升公司内在价值以回报广大投资者；同时，公司也通过多渠道、多方面与投资者保持良性互动，积极向市场传递公司投资价值。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-02-04/doc-inhksktz9542873.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-02-04/doc-inhksktz9542873.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0060","600422","BK0028","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778171523776,"stockEarnings":[{"period":"1week","weight":-0.0179},{"period":"1month","weight":-0.1787},{"period":"3month","weight":-0.2554},{"period":"6month","weight":-0.3114},{"period":"1year","weight":-0.3876},{"period":"ytd","weight":-0.2572}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0745},{"period":"3month","weight":0.0282},{"period":"6month","weight":0.0457},{"period":"1year","weight":0.2505},{"period":"ytd","weight":0.0532}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"昆药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"55570人(较上一季度增加0.29%)","perCapita":"13622股","listingDate":"2000-12-06","address":"云南省昆明市五华区国家高新技术产业开发区科医路166号","registeredCapital":"75697万元","survey":" 昆药集团股份有限公司的主营业务是药物研发、生产及销售、医药流通及大健康产业。公司的主要产品是心脑血管治疗领域、骨科系列、抗疟类、妇科、消化系统、其他、药品、器械批发与零售。公司是国家认定企业技术中心、国家高新技术创新示范企业、国家知识产权示范企业，全国医药制造业百强企业。","listedPrice":10.22},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昆药集团(600422)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昆药集团(600422)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昆药集团,600422,昆药集团股票,昆药集团股票老虎,昆药集团股票老虎国际,昆药集团行情,昆药集团股票行情,昆药集团股价,昆药集团股市,昆药集团股票价格,昆药集团股票交易,昆药集团股票购买,昆药集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昆药集团(600422)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昆药集团(600422)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}